Amryt Due For Oral Explanation At EMA For Epidermolysis Bullosa Gel Filsuvez

Capmatinib Developer May Also Make Its Case Before The CHMP

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".